Diabetes Care Innovation: The Price of Closing the Loop

August 23, 2017 | State of the Market Report

A rise in disease prevalence and in per-capita cost together signal that new solutions are needed to supplement, or replace, traditional diabetes management tools. Patient empowerment and self-care have widely been deemed the key to effective – and cheaper – diabetes management and prevention; however, gaps in education and in means exist. To address these gaps, players large and small are looking to crack the code for the perfect formula for self-management. While most hype has been dedicated to the “artificial pancreas," or the closed-loop insulin delivery system, innovation is also reshaping other primary aspects of diabetes management (e.g. nutrition and weight management, physical activity, and blood glucose monitoring). In this report, we landscape innovation in diabetes management, highlight strengths and pitfalls of emerging solutions, and comment on the price of closing the diabetes feedback loop (or the ability of these emerging solutions to empower self-management). We also outline action items for traditional diabetes players as well as newcomers, so that together they can deliver on the common vision of cheaper, more effective diabetes care.

Coverage Areas

  • Consumer Choices in Food, Health, and Wellness
  • Digital Health and Wellness
  • Digital Transformation

Table of Contents

  • Title page
  • Landscape I: Making sense of the diabetes hype
  • Landscape II: Understanding diabetes: The four pillars of management and prevention
  • Landscape III: Innovation is transforming all aspects of diabetes management
  • Analysis I: Can innovation close the loop?
  • Analysis II: Putting a price on closing the loop
  • Conclusions & Outlook
  • Appendix

Lead Analyst

Noa Ghersin
Analyst
+1 (857) 305-5280

Contributors

Sara Olson
Joseph Sweeny

Login to View This Research

Already a Lux Client?

Sign In

Not a Lux Client?

Talk to Lux Research now and learn the benefits of becoming a member.

Lux Research

  • Helps clients find new business opportunities from emerging technologies in the physical and life sciences
  • Offers ongoing technology and market intelligence, as well as market data and consulting services
  • Now serves over 250 clients on six continents – multinational corporations, investors, governments, and SMEs
  • Has a Global reach, with offices in Boston, New York, Amsterdam, Singapore, and Tokyo
  • Combines deep technical expertise with business analysis to support strategic decisions

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978